Rutgers COVID-19 Cohort Study
Public ClinicalTrials.gov record NCT04336215. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease severity in a large healthcare system. We addressed this hypothesis by recruiting and longitudinally following 546 HCW and a comparison group of 283 non-HCW within a large academic health system, Rutgers Biomedical and Health Sciences (RBHS). By intensively following participants over a several year period (2020-2024) and collecting serial biospecimens (nasopharyngeal/throat swabs, blood, and saliva) and questionnaire data at multiple time points, we will uniquely characterize SARS-CoV-2 transmission and risk factors for COVID-19 among HCW and our larger academic community.
Study identification
- NCT ID
- NCT04336215
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 829 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 7, 2020 (Actual)
- Primary completion
- Aug 31, 2024 (Actual)
- Completion
- Aug 31, 2024 (Actual)
- Last update posted
- May 15, 2026
2020 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower - | New Brunswick | New Jersey | 08901 | — |
| Robert Wood Johnson University Hospital | New Brunswick | New Jersey | 08901 | — |
| Clinical Research Unit Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | — |
| Rutgers School of Dental Medicine | Newark | New Jersey | 07103 | — |
| University Hospital | Newark | New Jersey | 07103 | — |
| Environmental and Occupational Health Sciences Institute | Piscataway | New Jersey | 08854 | — |
| RUCDR Infinite Biologics | Piscataway | New Jersey | 08854 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04336215, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04336215 live on ClinicalTrials.gov.